Wonwoo Jeong, PhD
Staff Scientist (Apr. 2026~)
Wake Forest Institute for Regenerative medicine, NC
Biomedical engineer, specializing in New Approach Methodologies (NAMs), 3D bioprinting, tissue engineering, and translational regenerative medicine.
Professional Service
Young Investigator Committee (YIC) and the CTRMS Enabling Technologies Working Group, Cell Transplant and Regenerative Medicine Society (CTRMS)
Research has focused on
-High Throughput Drug Screening of Patients-Derived Cancer Organoids with Tumor Microenvironment
-In Vitro Complex Model for Toxicology iPSC-derived Organoids with ECM and Stromal Tissue; Kideny, Liver, and Muscle
-AI-Powered Machine Learning in Target Discovery for tissue/organ equivalents
-Developing Clinically Relevant Bio-inks for Regenerative Medicine
Candidate of DABT (Diplomate of the American Board of Toxicology 2026~)
Research Interests
My research deeply focused translational regenerative medicine, with a strong emphasis on interdisciplinary application in 3D bioprinting.
Translational Drug Screening and Toxicology Using Human-Relevant Organoid Models
Development of patient- and iPSC-derived organoid-based NAMs to evaluate organ-specific toxicity, dose–response relationships, and mechanisms of toxicity within spatially defined ECM and stromal microenvironments.
Global Leadership in Translational Bioengineering
Leading international, multidisciplinary collaborations with clinicians, engineers, and researchers to develop clinically relevant bioinks, artificial organ systems, and patient-derived disease models that advance bioprinting technologies toward preclinical and clinical translation.
Peer-reviewed Publications
Jeong et al., High throughput screening of patient-derived cancer organoids by improving physiological relevance with basement membrane matrix for clinical application. Acta Biomaterialia, (2025)
Jeong et al., A bio-printed breast cancer-adipose intact tissue model mimicking distance-dependent paracrine interaction to evaluate chemo- and adipokines-targeted therapies. Advanced Healthcare Materials (2025)
Lee and Jeong et al., 3D Bioprinting for Engineered Tissue Constructs and Patient‐Specific Models: Current Progress and Prospects in Clinical Applications.
Advanced Materials (2024)